1. Home
  2. IDR vs BWAY Comparison

IDR vs BWAY Comparison

Compare IDR & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Idaho Strategic Resources Inc.

IDR

Idaho Strategic Resources Inc.

HOLD

Current Price

$42.54

Market Cap

684.7M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.41

Market Cap

674.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDR
BWAY
Founded
1996
2003
Country
United States
Israel
Employees
N/A
129
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
684.7M
674.2M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
IDR
BWAY
Price
$42.54
$16.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.25
AVG Volume (30 Days)
218.8K
131.1K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
70.15
N/A
EPS
1.14
N/A
Revenue
$42,406,253.00
N/A
Revenue This Year
$25.52
$309.69
Revenue Next Year
N/A
$26.21
P/E Ratio
$38.29
$81.98
Revenue Growth
64.59
N/A
52 Week Low
$12.25
$8.61
52 Week High
$54.70
$26.63

Technical Indicators

Market Signals
Indicator
IDR
BWAY
Relative Strength Index (RSI) 57.22 56.96
Support Level $41.55 $14.56
Resistance Level $46.85 $16.63
Average True Range (ATR) 2.33 0.62
MACD -0.04 0.22
Stochastic Oscillator 48.36 71.03

Price Performance

Historical Comparison
IDR
BWAY

About IDR Idaho Strategic Resources Inc.

Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. The Company's primary business is exploring for, developing, and extracting gold, and to a lesser extent, silver, and base metal mineral resources in the greater Coeur d'Alene Mining District of North Idaho. The Company produces gold at the Golden Chest Mine located in the Murray Gold Belt area of the world-class Coeur d'Alene Mining District, north of the prolific Silver Valley.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: